We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.71B
AUM Growth
+$45M
Cap. Flow
+$149M
Cap. Flow %
8.73%
Top 10 Hldgs %
22.6%
Holding
143
New
5
Increased
66
Reduced
20
Closed
7

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$25.4M
2
MRK icon
Merck
MRK
+$19.4M
3
TGT icon
Target
TGT
+$19.1M
4
PSA icon
Public Storage
PSA
+$17.4M
5
JCI icon
Johnson Controls International
JCI
+$17.3M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$27.1M
2
CSCO icon
Cisco
CSCO
+$20.4M
3
AVGO icon
Broadcom
AVGO
+$16.9M
4
WH icon
Wyndham Hotels & Resorts
WH
+$15.4M
5
DLR icon
Digital Realty Trust
DLR
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.18%
2 Financials 13.65%
3 Technology 11.48%
4 Energy 10.86%
5 Industrials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.07T
$48.2M 2.82%
149,100
-3,600
-2% -$1.14M
UNH icon
2
UnitedHealth
UNH
$382B
$47.5M 2.78%
94,110
+2,400
+3% +$1.26M
CVS icon
3
CVS Health
CVS
$137B
$38.8M 2.27%
407,200
+8,700
+2% +$861K
NEE icon
4
NextEra Energy
NEE
$187B
$38.4M 2.25%
490,300
+6,500
+1% +$551K
GD icon
5
General Dynamics
GD
$105B
$37.9M 2.22%
178,830
+6,400
+4% +$1.45M
PFE icon
6
Pfizer
PFE
$140B
$37.3M 2.18%
853,490
+20,800
+2% +$1.01M
AJG icon
7
Arthur J. Gallagher & Co
AJG
$63.7B
$36.3M 2.12%
211,800
+4,900
+2% +$870K
MRK icon
8
Merck
MRK
$324B
$34.8M 2.04%
404,210
+216,800
+116% +$19.4M
ABBV icon
9
AbbVie
ABBV
$458B
$33.7M 1.97%
251,070
+4,500
+2% +$646K
PSX icon
10
Phillips 66
PSX
$82.9B
$33.2M 1.94%
411,900
+3,300
+0.8% +$281K
JPM icon
11
JPMorgan Chase
JPM
$939B
$32.7M 1.91%
312,560
+83,700
+37% +$9.61M
KO icon
12
Coca-Cola
KO
$354B
$32.1M 1.88%
573,220
+12,600
+2% +$783K
BMY icon
13
Bristol-Myers Squibb
BMY
$127B
$31.8M 1.86%
447,260
+77,800
+21% +$5.64M
CB icon
14
Chubb
CB
$140B
$31.5M 1.84%
173,170
+31,000
+22% +$5.89M
ELV icon
15
Elevance Health
ELV
$81.9B
$30.2M 1.76%
66,400
+27,200
+69% +$13M
MSFT icon
16
Microsoft
MSFT
$2.84T
$30.1M 1.76%
129,230
+42,800
+50% +$11.3M
EXC icon
17
Exelon
EXC
$48.6B
$29.6M 1.73%
789,900
+13,400
+2% +$592K
MET icon
18
MetLife
MET
$61B
$29.5M 1.72%
484,640
+9,500
+2% +$607K
RSG icon
19
Republic Services
RSG
$66.7B
$28.9M 1.69%
212,420
+5,200
+3% +$727K
PLD icon
20
Prologis
PLD
$138B
$28.6M 1.67%
281,300
+83,600
+42% +$10.4M
DUK icon
21
Duke Energy
DUK
$102B
$28.5M 1.67%
306,090
+101,300
+49% +$10.9M
D icon
22
Dominion Energy
D
$62.5B
$28.4M 1.66%
411,300
+172,200
+72% +$13.9M
PEP icon
23
PepsiCo
PEP
$186B
$27.5M 1.61%
168,700
+33,500
+25% +$5.77M
SPY icon
24
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$26.9M 1.58%
75,427
-13,957
-16% -$5.54M
PAYX icon
25
Paychex
PAYX
$40.4B
$26.8M 1.57%
239,230
+4,200
+2% +$521K
1
2 3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2022 Portfolio in Review

As of Q3 2022, Payden & Rygel held 143 positions worth $1.71B, up 2.7% from $1.66B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Payden & Rygel deployed $149M of net new capital in Q3 2022, opening 5 new positions and adding to 66 existing holdings. Its largest new stake was Johnson Controls International: 327,100 shares worth $16.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $27.1M trimmed.

  • Payden & Rygel's largest Q3 2022 buy was Johnson Controls International: 327,100 shares worth $16.1M.
  • Payden & Rygel added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2022, an estimated $25.4M increase.
  • Payden & Rygel's biggest Q3 2022 reduction was Verizon, cutting an estimated $27.1M.
  • Payden & Rygel fully exited Sun Communities in Q3 2022, selling an estimated $8.37M.
  • Payden & Rygel's ten largest holdings make up 23% of its $1.71B portfolio in Q3 2022.
  • Payden & Rygel opened 5 new positions and closed 7 in Q3 2022.
  • Payden & Rygel's portfolio value rose 2.7% quarter-over-quarter to $1.71B.

Based on Payden & Rygel's 13F filing for Q3 2022, filed 10 Nov 2022.